| Product Code: ETC10765546 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Pemetrexed Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Pemetrexed Market - Industry Life Cycle |
3.4 South Korea Pemetrexed Market - Porter's Five Forces |
3.5 South Korea Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 South Korea Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 South Korea Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 South Korea Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 South Korea Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 South Korea Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lung cancer in South Korea |
4.2.2 Growing awareness about the efficacy of pemetrexed in cancer treatment |
4.2.3 Government initiatives to improve healthcare infrastructure and access to advanced treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new drugs |
4.3.2 High cost of pemetrexed treatment |
4.3.3 Competition from alternative cancer treatment options |
5 South Korea Pemetrexed Market Trends |
6 South Korea Pemetrexed Market, By Types |
6.1 South Korea Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 South Korea Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 South Korea Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 South Korea Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 South Korea Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 South Korea Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 South Korea Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 South Korea Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 South Korea Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 South Korea Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 South Korea Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 South Korea Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 South Korea Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 South Korea Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 South Korea Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 South Korea Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 South Korea Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 South Korea Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 South Korea Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 South Korea Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 South Korea Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 South Korea Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 South Korea Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 South Korea Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 South Korea Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 South Korea Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 South Korea Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 South Korea Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 South Korea Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 South Korea Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 South Korea Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 South Korea Pemetrexed Market Import-Export Trade Statistics |
7.1 South Korea Pemetrexed Market Export to Major Countries |
7.2 South Korea Pemetrexed Market Imports from Major Countries |
8 South Korea Pemetrexed Market Key Performance Indicators |
8.1 Average time taken for regulatory approval of new drugs in South Korea |
8.2 Number of clinical trials and research studies on pemetrexed in South Korea |
8.3 Patient adherence rate to pemetrexed treatment plan |
9 South Korea Pemetrexed Market - Opportunity Assessment |
9.1 South Korea Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 South Korea Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 South Korea Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 South Korea Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 South Korea Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 South Korea Pemetrexed Market - Competitive Landscape |
10.1 South Korea Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 South Korea Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here